Last reviewed · How we verify
NCT03254875: REBECCA II
Rehabilitation After Breast Cancer
NA trial testing Individually tailored nurse navigation in Breast Cancer in 309 participants. Completed in 31 March 2021.
31 March 2021
Quick facts
| Lead sponsor | Danish Cancer Society |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 309 |
| Start date | 15 August 2017 |
| Primary completion | 31 March 2021 |
| Estimated completion | 31 March 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Individually tailored nurse navigation
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Danish Cancer Society
Who can join
18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate whether a screening-based individually tailored nurse navigator intervention compared to standard care significantly reduce psychological and physical symptoms among women being treated for breast cancer who had moderate-to-severe distress (score ≥ 7 on the distress thermometer).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of a Nurse Navigation Intervention on Mental Symptoms in Patients With Psychological Vulnerability and Breast Cancer: The REBECCA Randomized Clinical Trial.
Bidstrup PE, Johansen C, Kroman N, Belmonte F, et al · · 2023 · cited 19× · PMID 37351885 · DOI 10.1001/jamanetworkopen.2023.19591 -
Are breast cancer patients with low distress at diagnosis at risk of psychological symptoms later in their disease trajectory? Considerations for when to screen for distress.
Langballe R, Mertz B, Kroman N, Maltesen T, et al · · 2025 · cited 2× · PMID 39863933 · DOI 10.2340/1651-226x.2025.42367
Verify or expand the search:
- PubMed search for NCT03254875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Danish Cancer Society trials
Trials by the same sponsor.
- NCT03444532 — Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia · NA · completed
- NCT03692000 — Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03254875 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danish Cancer Society
- Last refreshed: 27 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03254875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing